Skip to main content
. 2015 Apr 6;33(14):1557–1563. doi: 10.1200/JCO.2014.58.6750

Fig 1.

Fig 1.

Survival from time of progression in patients for whom allogeneic stem-cell transplantation failed. (A) The median overall survival (OS) of the entire cohort was 35 months (95% CI, 30 to 40 months). (B) Diagnosis at the time of transplantation predicted survival: OS is shown for patients who had chronic lymphocytic leukemia (CLL; median OS, 36 months; 95% CI, 24 to 48 months) or Richter's transformation (RT) at the time of transplantation (median OS, 15 months; 95% CI, 2 to 28 months). (C) Presence of acute graft-versus-host disease (GVHD) predicted survival: OS is shown for patients who developed acute GVHD after stem-cell transplantation (median OS, 45 months; 95% CI, 28 to 61 months) and those who had no acute GVHD (median OS, 29 months; 95% CI, 17 to 41 months). (D) Presence of chronic GVHD predicted survival: OS is shown for patients who developed chronic GVHD after stem-cell transplantation (median OS, 37 months; 95% CI, 23 to 51 months) and patients who did not develop chronic GVHD (median OS, 23 months; 95% CI, 5 to 41 months).